Can Narrative Medicine Methods Improve Well-Being in Patients With GI Malignancies
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 2
- 主要终点
- Number of participants who complete the narrative medicine sessions
研究概览
简要总结
This clinical trial assesses whether narrative medicine methods may improve the sense of well-being among gastrointestinal (GI) (digestive system) cancer patients. Narrative medicine is a clinical approach where providers can use a patient's own narrative (perspective) of their illness to promote healing and resilience. By applying narrative medicine's main tool, close reading, to clinical practice, clinicians learn to listen and attend to patients more deeply. This allows for freer communication and the creation of a healthcare encounter that centers on the psychological and emotional well being of the patient in addition to their medical conditions. Narrative medicine can include close reading, creative or reflective writing, and discussion. These methods may help patients with GI cancer to reflect on their life stories, both inside and outside of their illness experience, and help them gather skills to optimize their well-being.
详细描述
PRIMARY OBJECTIVES:
I. To assess the feasibility of implementing narrative medicine tools in serial workshops with patients with malignancy.
II. To determine if narrative medicine interventions improve markers and expressions of well-being.
DESCRIPTIVE OBJECTIVES:
I. To estimate changes in markers and expressions of well-being after 3 sessions of narrative medicine intervention.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with diagnosis of gastrointestinal malignancy actively receiving infusional therapy for cancer.
- •Age >= 18 years.
- •English speaking with ability to participate in reading and writing questionnaires and implementation tools.
- •Performance Status =< Eastern Cooperative Oncology Group (ECOG) 3.
排除标准
- •Altered mental status or other cognitive impairment, organic or drug induced that would limit ability to participate in the evaluation.
结局指标
主要结局
Number of participants who complete the narrative medicine sessions
时间窗: Up to 3 months
To determine the intervention feasibility, the number of participants who complete the narrative medicine sessions will be tracked.
Change in well-being scores
时间窗: Up to 3 months
Will be evaluated using the Edmonton Symptom Assessment System-Revised Version (ESAS-r). The total score ranges from 0 to 10, with a higher score indicating worse outcomes.
次要结局
未报告次要终点
